微信公众号
News Center
Good news! Kaqiu Biotech's self-developed CATYS series dyeing machine has been approved for Class I certification!
Jun 13,2023
Warm congratulations to CATYS Bio for independently developing the CATYS series of immunohistochemical staining machines and successfully obtaining the Class I medical device registration certificate!
△CATYS Bio CATYS 48
The CATYS series fully automatic immunohistochemical staining machines are medical devices developed independently by CATYS Bio based on years of technical accumulation and market demand, serving pathology.
This product features a fully automated staining process and a streamlined, easy-to-use digital operating system, compatible with various staining platforms including IHC, ICC, ISH, mIHC, and IF. It can provide fast and accurate bright-field and dark-field immunohistochemical/cytochemical staining services for clinical pathological diagnosis, with broad application prospects.
△CATYS48 in operation
At the same time, the CATYS series is equipped with an independent temperature control system and liquid film covering technology, allowing single-slide independent control. Each staining rack can run different staining programs independently, enabling one device to easily handle conventional IHC, multiplex staining, frozen IHC, in situ hybridization, and other staining methods.
As early as 2016, the State Council issued the "13th Five-Year National Science and Technology Innovation Plan" (Guo Fa [2016] No. 43), which clearly emphasized the key deployment of domestic products in the field of in vitro diagnostic products, specifically mentioning the development of major products such as rapid pathological diagnosis systems to enhance the competitiveness of China's in vitro diagnostic industry.
△CATYS series staining examples
This time, the CATYS series fully automatic immunohistochemical staining machines have successfully obtained the Class I medical device registration certificate, which not only highlights the technical strength but will also further enhance CATYS Bio's competitiveness in the domestic immunohistochemical market, laying a solid foundation for the company's development.
CATYS Bio has long been committed to the research and development of immunohistochemical antibody proteins, molecular reagents, companion diagnostics, and gene methylation detection reagents required for precision oncology medicine, providing more advanced and efficient solutions for clinical diagnosis. We believe that in the future, we will continue to leverage our technological advantages and innovation capabilities to make greater contributions to the development of pathological diagnosis!
Contact Us
Consultation phone: 400 000 8876
Recruitment service: pingping@calt-bio.com
Business cooperation: pingping@calt-bio.com
Company address: Building A8, Huizhi Technology Park, High-tech Industrial Park, Nanjing